Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study

Open access

Abstract

Objective: Hepatocellular carcinoma (HCC) is an infrequent yet critical event in primary biliary cirrhosis (PBC); however, predictive tools remain ill-defined. Our objective was to identify candidate risk factors for HCC development in patients with PBC. Design: Risk factor analysis was performed in over 15 centres from North America and Europe spanning >40 years observation period using Cox proportional hazards assumptions, logistic regression, and Kaplan-Meier estimates. Results: Of 4565 patients with PBC 123 developed HCC, yielding an incidence rate (IR) of 3.4 cases/1000 patient-years. HCC was significantly more common in men (p<0.0001), and on univariate analysis factors at PBC diagnosis associated with future HCC development were male sex (unadjusted HR 2.91, p<0.0001), elevated serum aspartate transaminase (HR 1.24, p<0.0001), advanced disease (HR 2.72, p=0.022), thrombocytopenia (HR 1.65, p<0.0001), and hepatic decompensation (HR 9.89, p<0.0001). As such, non-treatment with ursodeoxycholic acid itself was not associated with cancer development; however, 12-month stratification by biochemical non-response (Paris-I criteria) associated significantly with future risk of HCC (HR 4.52, p<0.0001; IR 6.6 vs 1.4, p<0.0001). Non-response predicted future risk in patients with early stage disease (IR 4.7 vs 1.2, p=0.005), advanced disease (HR 2.79, p=0.02; IR 11.2 vs 4.4, p=0.033), and when restricting the analysis to only male patients (HR 4.44, p<0.001; IR 18.2 vs 5.4, p<0.001). On multivariable analysis biochemical non-response remained the most significant factor predictive of future HCC risk (adjusted HR 3.44, p<0.0001). Conclusions: This uniquely powered, internationally representative cohort robustly demonstrates that 12-month biochemical non-response is associated with increased future risk of developing HCC in PBC. Such risk stratification is relevant to patient care and development of new therapies.

Overview

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2014-308351

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 42 references

Research works printed but not linked: 1

  1. 10.1002/hep.26725 · doi:10.1002/hep.26725

Cited by

See all 178

Metadata

Authors
Trivedi, P. J., Lammers, W. J., van Buuren, H. R., Parés, A., Floreani, A., Janssen, H. L. A., Invernizzi, P., Battezzati, P. M., Ponsioen, C. Y., Corpechot, C., Poupon, R., Mayo, M. J., Burroughs, A. K., Nevens, F., Mason, A. L., Kowdley, K. V., Lleo, A., Caballeria, L., Lindor, K. D., Hansen, B. E., & Hirschfield, G. M.
Affiliations
  • Queen Elizabeth Hospital Birmingham (GB)
  • Erasmus MC (NL)
  • Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands
  • Hospital Clínic de Barcelona (ES)
  • University of Padua (IT)
  • University Health Network (CA)
  • Humanitas University (IT)
  • University of Milan (IT)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Assistance Publique – Hôpitaux de Paris (FR)
  • The University of Texas Southwestern Medical Center (US)
  • The Royal Free Hospital (GB)
  • Universitair Ziekenhuis Leuven (BE)
  • University of Alberta (CA)
  • Virginia Mason Medical Center (US)
  • Liver Unit and Center for Autoimmune Liver Diseases, Humanitas Clinical and Research Center, Rozzano (MI), Italy
  • Liver Unit, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Spain
  • Mayo Clinic (US)
Corresponding author
Hirschfield, Gideon M
Venue
Gut
Publisher
BMJ
Published
2015-01-07
Volume
65
Issue
2
Pages
321-329
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2141267824
Cited by
178
References
42
Citations by year
2026: 8 · 2025: 10 · 2024: 14 · 2023: 20 · 2022: 11 · 2021: 15 · 2020: 15 · 2019: 17 · 2018: 21 · 2017: 21 · 2016: 13 · 2015: 12
FWCI
13.17
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Gut (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
  • Lirias (KU Leuven) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Funders
  • Wellcome Trust (099907/Z/12/Z)
  • Intercept Pharmaceuticals
  • Medical Research Council
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
Keywords
hepatocellular carcinoma, primary biliary cirrhosis, HCC risk factors, ursodeoxycholic acid, Paris criteria, hepatic decompensation, thrombocytopenia, sex differences, cancer incidence, risk stratification, cholestatic liver disease, hepatocarcinogenesis, hepatocellular adenoma
MeSH terms
Aspartate Aminotransferases, Europe, Female, Carcinoma, Hepatocellular, Humans, Liver Cirrhosis, Biliary, Liver Neoplasms, Male, North America, Risk, Risk Factors, Sex Factors, Thrombocytopenia, Ursodeoxycholic Acid, Logistic Models, Proportional Hazards Models, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study. https://app.cochat.ai/papers/10.1136/gutjnl-2014-308351
The paper
Trivedi, P. J., Lammers, W. J., van Buuren, H. R., Parés, A., Floreani, A., Janssen, H. L. A., Invernizzi, P., Battezzati, P. M., Ponsioen, C. Y., Corpechot, C., Poupon, R., Mayo, M. J., Burroughs, A. K., Nevens, F., Mason, A. L., Kowdley, K. V., Lleo, A., Caballeria, L., Lindor, K. D., . . . Hirschfield, G. M. (2016). Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study. Gut. https://doi.org/10.1136/gutjnl-2014-308351

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.